109 related articles for article (PubMed ID: 35495859)
1.
Hiraide T; Suzuki H; Shinya Y; Momoi M; Inami T; Katsumata Y; Fukuda K; Kosaki K; Kataoka M
CJC Open; 2022 Apr; 4(4):416-419. PubMed ID: 35495859
[TBL] [Abstract][Full Text] [Related]
2. Novel Mutations and Decreased Expression of the Epigenetic Regulator
Potus F; Pauciulo MW; Cook EK; Zhu N; Hsieh A; Welch CL; Shen Y; Tian L; Lima P; Mewburn J; D'Arsigny CL; Lutz KA; Coleman AW; Damico R; Snetsinger B; Martin AY; Hassoun PM; Nichols WC; Chung WK; Rauh MJ; Archer SL
Circulation; 2020 Jun; 141(24):1986-2000. PubMed ID: 32192357
[TBL] [Abstract][Full Text] [Related]
3. Whole Exome Sequencing of Patients With Heritable and Idiopathic Pulmonary Arterial Hypertension in Central Taiwan.
Liang KW; Chang SK; Chen YW; Lin WW; Tsai WJ; Wang KY
Front Cardiovasc Med; 2022; 9():911649. PubMed ID: 35811711
[TBL] [Abstract][Full Text] [Related]
4. Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension.
Hiraide T; Kataoka M; Suzuki H; Aimi Y; Chiba T; Isobe S; Katsumata Y; Goto S; Kanekura K; Yamada Y; Moriyama H; Kitakata H; Endo J; Yuasa S; Arai Y; Hirose N; Satoh T; Hakamata Y; Sano M; Gamou S; Kosaki K; Fukuda K
J Heart Lung Transplant; 2020 Feb; 39(2):103-112. PubMed ID: 31542298
[TBL] [Abstract][Full Text] [Related]
5. TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan.
Shaikh ARK; Ujjan I; Irfan M; Naz A; Shamsi T; Khan MTM; Shakeel M
PeerJ; 2021; 9():e10678. PubMed ID: 33643703
[TBL] [Abstract][Full Text] [Related]
6. Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension.
Abbasi Y; Jabbari J; Jabbari R; Glinge C; Izadyar SB; Spiekerkoetter E; Zamanian RT; Carlsen J; Tfelt-Hansen J
Mol Genet Genomic Med; 2018 Sep; 6(5):835-844. PubMed ID: 30084161
[TBL] [Abstract][Full Text] [Related]
7. Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient.
Ma Q; Guo Y; Lan X; Wang G; Sun W
BMC Med Genomics; 2021 Jun; 14(1):158. PubMed ID: 34120595
[TBL] [Abstract][Full Text] [Related]
8. Pedigree investigation, clinical characteristics, and prognosis analysis of haematological disease patients with germline TET2 mutation.
Wu X; Deng J; Zhang N; Liu X; Zheng X; Yan T; Ye W; Gong Y
BMC Cancer; 2022 Mar; 22(1):262. PubMed ID: 35279121
[TBL] [Abstract][Full Text] [Related]
9. Identification of a low frequency missense mutation in MUC6 contributing to pulmonary artery hypertension by whole-exome sequencing.
Zou L; Li W; Han J; Yang Y; Jin J; Xiao F; Xu X; Zhai Z
Pulm Circ; 2018; 8(3):2045894018794374. PubMed ID: 30047301
[TBL] [Abstract][Full Text] [Related]
10. Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.
Stearman RS; Cornelius AR; Lu X; Conklin DS; Del Rosario MJ; Lowe AM; Elos MT; Fettig LM; Wong RE; Hara N; Cogan JD; Phillips JA; Taylor MR; Graham BB; Tuder RM; Loyd JE; Geraci MW
Am J Respir Crit Care Med; 2014 May; 189(9):1110-20. PubMed ID: 24605778
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups.
D'Addario CA; Lanier GM; Jacob C; Bauer N; Hewes JL; Bhadra A; Gupte SA
Physiol Rep; 2022 May; 10(10):e15282. PubMed ID: 35581740
[TBL] [Abstract][Full Text] [Related]
12. Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.
Bohnen MS; Ma L; Zhu N; Qi H; McClenaghan C; Gonzaga-Jauregui C; Dewey FE; Overton JD; Reid JG; Shuldiner AR; Baras A; Sampson KJ; Bleda M; Hadinnapola C; Haimel M; Bogaard HJ; Church C; Coghlan G; Corris PA; Eyries M; Gibbs JSR; Girerd B; Houweling AC; Humbert M; Guignabert C; Kiely DG; Lawrie A; MacKenzie Ross RV; Martin JM; Montani D; Peacock AJ; Pepke-Zaba J; Soubrier F; Suntharalingam J; Toshner M; Treacy CM; Trembath RC; Vonk Noordegraaf A; Wharton J; Wilkins MR; Wort SJ; Yates K; Gräf S; Morrell NW; Krishnan U; Rosenzweig EB; Shen Y; Nichols CG; Kass RS; Chung WK
Circ Genom Precis Med; 2018 Oct; 11(10):e002087. PubMed ID: 30354297
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Characterization of
Hadinnapola C; Bleda M; Haimel M; Screaton N; Swift A; Dorfmüller P; Preston SD; Southwood M; Hernandez-Sanchez J; Martin J; Treacy C; Yates K; Bogaard H; Church C; Coghlan G; Condliffe R; Corris PA; Gibbs S; Girerd B; Holden S; Humbert M; Kiely DG; Lawrie A; Machado R; MacKenzie Ross R; Moledina S; Montani D; Newnham M; Peacock A; Pepke-Zaba J; Rayner-Matthews P; Shamardina O; Soubrier F; Southgate L; Suntharalingam J; Toshner M; Trembath R; Vonk Noordegraaf A; Wilkins MR; Wort SJ; Wharton J; ; Gräf S; Morrell NW
Circulation; 2017 Nov; 136(21):2022-2033. PubMed ID: 28972005
[TBL] [Abstract][Full Text] [Related]
14. TET2 missense variants in human neoplasia. A proposal of structural and functional classification.
Bussaglia E; Antón R; Nomdedéu JF; Fuentes-Prior P
Mol Genet Genomic Med; 2019 Jul; 7(7):e00772. PubMed ID: 31187595
[TBL] [Abstract][Full Text] [Related]
15. A genome-wide association analysis identifies
Kimura M; Tamura Y; Guignabert C; Takei M; Kosaki K; Tanabe N; Tatsumi K; Saji T; Satoh T; Kataoka M; Kamitsuji S; Kamatani N; Thuillet R; Tu L; Humbert M; Fukuda K; Sano M
Oncotarget; 2017 Sep; 8(43):74917-74926. PubMed ID: 29088834
[TBL] [Abstract][Full Text] [Related]
16.
Song J; Hinderhofer K; Kaufmann LT; Benjamin N; Fischer C; Grünig E; Eichstaedt CA
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33036198
[TBL] [Abstract][Full Text] [Related]
17. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension.
Hemnes AR; Zhao M; West J; Newman JH; Rich S; Archer SL; Robbins IM; Blackwell TS; Cogan J; Loyd JE; Zhao Z; Gaskill C; Jetter C; Kropski JA; Majka SM; Austin ED
Am J Respir Crit Care Med; 2016 Aug; 194(4):464-75. PubMed ID: 26926454
[TBL] [Abstract][Full Text] [Related]
18. A novel channelopathy in pulmonary arterial hypertension.
Ma L; Roman-Campos D; Austin ED; Eyries M; Sampson KS; Soubrier F; Germain M; Trégouët DA; Borczuk A; Rosenzweig EB; Girerd B; Montani D; Humbert M; Loyd JE; Kass RS; Chung WK
N Engl J Med; 2013 Jul; 369(4):351-361. PubMed ID: 23883380
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
Waxman AB; Zamanian RT
Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis of pulmonary arterial hypertension: a prospective study from a highly inbred population.
Aldalaan AM; Ramzan K; Saleemi SA; Weheba I; Alquait L; Abdelsayed A; Alzubi F; Zaytoun H; Alharbi N; Al-Owain M; Imtiaz F
Pulm Circ; 2021; 11(3):20458940211032057. PubMed ID: 34377436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
